HCA Healthcare price target raised to $452 from $431 at Wells Fargo

Wells Fargo analyst Stephen Baxter raised the firm’s price target on HCA Healthcare (HCA) to $452 from $431 and keeps an Equal Weight rating on the shares. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.